THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

VanEck and State Street Clash Over Biotech ETF Focus

Key PointsThe VanEck Biotech ETF and State Street SPDR S&P Pharmaceuticals ETF both carry an identical expense ratio of 0. 35%.

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights